proceedings of the tender evaluation committee meeting in ... · proceedings of the tender...
TRANSCRIPT
1 | P a g e
PROCEEDINGS OF THE TENDER EVALUATION COMMITTEE MEETING IN THE CONFERENCE HALL OF OSMC ON 27.06.2015, 11:30 AM FOR THE EVALUATION OF TECHNICAL BID FOR THE TENDER OF DIFFERENT TEST KITS, ANTI MALARIA DRUGS & ANTI MALARIA COMBIPACKS UNDER NVBDCP [Bid Ref. No-OSMCL/2014-15/OHC-DHS-Kit/02, OSMCL/2014-15/DRUGS-DHS-Mal./01 & OSMCL/2014-15/DRUGS-DHS-CP/02.]
The evaluation of the Technical Bids of 19 (nineteen) bidders for 3(three) categories are prepared and presented before the Tender Evaluation Committee. Out of the 19 (nineteen) bidders, 7(seven) bidders had participated for the tender of 2(two) Test kits, 8(eight) bidders had participated for 7(seven) no. of items (Anti-malaria drugs) & 4(four) bidders are participated for 5(five) no. of items (Anti-malaria combi-packs). The detailed technical evaluation statement is attached at Annexure-I, II & III respectively.
• The Committee went through the technical evaluation report for the 3(three) categories of tender in detail and observed the
following:-
1. DIFFERENT TEST KITS, (Bid ref. No- OSMCL/2014-15/OHC-DHS-Kit/02):
A. Bivalent Rapid Diagnostic Test Kit: Total 6 (six) bidders had participated in the above tender for this item. Out of the 6(six)
bidders, 3(three) bidders namely (1) M/s Meril Diagnostics Pvt. Ltd., Mumbai & (2) M/s. Orchid Biomedical Systems, Goa &
(3) ADVY Chemical Pvt. Ltd, Thane could not qualify in the technical bid evaluation & sample verification. The other 3(three)
bidders namely (1) M/s. Bhat Bio-Tech India (P) Ltd, Bangalore, (2) M/s. Aspen Laboratories Pvt Ltd, Delhi & (3) M/s. SD Bio-
Standard Diagnostics Pvt Ltd, Gurgaon became technically qualified as per the tender terms conditions, specification & after
sample verification. The detail of technical evaluation is attached at Annexure–I. The Committee approved the technical
evaluation statement for Bivalent Rapid Diagnostic Kit attached at Annexure – I.
2 | P a g e
B. NS1 Elisa Kit For Dengue Test: Only 1(one) bidder M/s. Alere Medical Pvt Ltd, Gurgaon, participated in the tender for this item
and also became technically qualified as per the tender terms conditions, specification & sample verification. The details of the
technical evaluation is attached at Annexure–I. The Committee approved the technical evaluation statement attached at
Annexure – I.
2. ANTI MALARIA DRUGS, (Bid ref. No- OSMCL/2014-15/DRUGS-DHS-Mal./01):-
Total 8(eight) bidders had participated for 7(seven) no. of tendered items. After technical bid evaluation it was found that all the
8(eight) bidders became technically qualified for their quoted items as per the tender terms conditions & specifications. The
detail of technical evaluation is attached at Annexure–II. The detail approved technical evaluation statement attached at
Annexure-II.
3. ANTI MALARIA COMBIPACKS, Bid ref. No- OSMCL/2014-15/DRUGS-DHS-CP/02:-
Total 4(four) bidders had participated for 5(five) no. of items (anti-malaria combipacks). After technical bid evaluation it was
found that only 2(two) bidders i.e. (1) M/s Zest Pharma, Indore & (2) M/s Unicure India Ltd., Noida became technically
qualified for all the quoted items. (3) M/s Healthy Life Pharma Pvt. Ltd, Mumbai became qualified for the items: Tab. Anti-
Malaria Combipack (Children 1-4 years), Tab. Anti-Malaria Combipack (Children 5-8 years), Tab. Anti-Malaria Combipack
(Children 9-14 years) & Tab. Anti-Malaria Combipack (Adult 15 years) but could not qualify for Tab. Anti-Malaria Combipack
(less than 1 years). (4) M/s Salud Care (Ind) Pvt. Ltd., Ahemedabad became qualified for the items of Tab. Anti-Malaria
Combipack (Children 9-14 years) & Tab. Anti-Malaria Combipack (Adult 15 years) but could not qualifiy for items Tab. Anti-
Malaria Combipack (less than 1 years), Tab. Anti-Malaria Combipack (Children 1-4 years) & for Tab. Anti-Malaria Combipack
3 | P a g e
(Children 5-8 years) as per the tender terms conditions & specification. The detail of technical evaluation is attached at
Annexure–III. The committee approved technical evaluation statement attached at Annexure-III.
Decisions Taken:
• The committee has recommended to open the Price Bid of the qualified bidders as mentioned in Annexure-I, II & III at the earliest
with prior intimation to the technically qualified bidders.
Sd/ Managing Director,
OSMC
Technical Evaluation for the Tenderof Diffrent Test Kits 2015 - 16
Bid Reference No. OSMCL/2014-15/OHC-DHS-KIT/02 Annexure : I
GMP / WHO GMP
Manufacturing/Import
License Specification Name of the Item Sl No. Remarks Reason of Rejection
ISO Market Experience of
( 30% )
Declaration Form
Unit / Pack Size
Annual Turn Over
EMD: Tender Cost (Rs. 2,100/- ): Yes 1 M/s. ASPEN LABORATORIES PVT. LTD. ,Delhi 25,60,000
As per tender specification
Bivalent Rapid Diagnostic Test Kit
S02110 1 10 test kits / box .
Valid upto 09/02/2020
Valid upto 17/07/2017
YES (Supply of more than 30% of the item or similar
items during last 3 years as per schedule of
requirement) based on clarification furnished by the
bidder.
Valid upto 22/09/2015
YES (The required Turn Over is
more than Rs. 5 Crores for each year during the last 3 financial
year)
Furnished Qualified after sample verification
& clarification
by the bidder.
EMD: Tender Cost (Rs. 2,100/- ): Yes 2 M/s. BHAT BIOTECH ,Bangalore 25,60,000
As per tender specification
Bivalent Rapid Diagnostic Test Kit
S02110 1 10 test kits / box .
Valid upto 01/05/2018
Valid upto 31/03/2018
YES (Supply of more than 30% of the item or similar
items during last 3 years as per schedule of
requirement)
Valid upto 31/12/2016
YES (The required Turn Over is
more than Rs. 5 Crores for each year during the last 3 financial
year)
Furnished Qualified after sample verification.
EMD: Tender Cost (Rs. 2,100/- ): Yes 3 M/s. ADVY CHEMICAL PVT. LTD. ,Thane 25,60,000
As per tender specification
Bivalent Rapid Diagnostic Test Kit
S02110 1 10 test kits / box .
Valid upto 21/10/2015
Valid upto 01/06/2015
YES (Supply of more than 30% of the item or similar
items during last 3 years as per schedule of
requirement)
GMP certificate furnished by the bidder is for Bulk Drugs/ API category of products
not for the quoted item.
Valid upto 07/12/2016
(GMP for the category of
bulk drug and API)
YES (The required Turn Over is
more than Rs. 5 Crores for each year during the last 3 financial
year)
Furnished Not Qualified
1
GMP / WHO GMP
Manufacturing/Import
License Specification Name of the Item Sl No. Remarks Reason of Rejection
ISO Market Experience of
( 30% )
Declaration Form
Unit / Pack Size
Annual Turn Over
EMD: Tender Cost (Rs. 2,100/- ): Yes 4 M/s. ALERE MEDICAL PVT. LTD. ,Gurgaon 1,15,000
As per tender specification
NS1 Elisa Kit For Dengue Test S02111 1 96 test kits / box Each
Valid upto 03/04/2017
Valid upto 31/08/2016
YES (Supply of more than 30% of the item or similar
items during last 3 years as per schedule of
requirement)
Valid upto 22/01/2014
YES (The required Turn Over is
more than Rs. 5 Crores for each year during the last 3 financial
year)
Furnished Qualified after sample verification.
EMD: Tender Cost (Rs. 2,100/- ): Yes 5 M/s. SD BIO STANDARD DIAGNOSTICS PVT. LTD. ,Gurgaon 25,60,000
As per tender specification
Bivalent Rapid Diagnostic Test Kit
S02110 1 10 test kits / box .
Valid upto 05/02/2017
Valid upto 18/10/2017
YES (Supply of more than 30% of the item or similar
items during last 3 years as per schedule of
requirement)
Valid upto 06/06/2016
YES (The required Turn Over is
more than Rs. 5 Crores for each year during the last 3 financial
year)
Furnished Qualified after sample verification.
EMD: Tender Cost (Rs. 2,100/- ): Yes 6 M/s. MERIL DIAGNOSTICS PRIVATE LIMITED ,Mumbai 25,60,000
As per tender specification
Bivalent Rapid Diagnostic Test Kit
S02110 1 10 test kits / box .
Valid upto 09/04/2018 (License in Form- 28 or Renewal in
Form- 26 not furnish)
Valid upto 05/12/2016
NO (As per
performance statement furnished does not have 30%
of the required quantity of Bivalent
Rapid Diagnostic Kit/ similar malaria
kits in the last 3 years)
Market experience is less than 30% of
schedule of requirement of Bivalent Rapid
Diagnostic Kit /similar malaria Kits in the last
3 years as per the tender clause No. 5.2.1 (e) & non submition of
sample.
Valid upto 30/06/2016
YES (The required Turn Over is
more than Rs. 5 Crores for each year during the last 3 financial
year)
Furnished Not Qualified
2
GMP / WHO GMP
Manufacturing/Import
License Specification Name of the Item Sl No. Remarks Reason of Rejection
ISO Market Experience of
( 30% )
Declaration Form
Unit / Pack Size
Annual Turn Over
EMD: Tender Cost (Rs. 2,100/- ): Yes 7 M/s. ORCHID BIOMEDICAL SYSTEMS ,Goa 25,60,000
As per tender specification
Bivalent Rapid Diagnostic Test Kit
S02110 1 10 test kits / box .
Valid upto 03/12/2017
Valid upto 16/08/2017
YES (Supply of more than 30% of the item or similar
items during last 3 years as per schedule of
requirement)
As per sample verification,the storage Temp.of the sample is found to be(4-30)oC as
per its label claim &documentary
evidence furnished in the Tech.bid, which is not matching with the
Tech. Spec. for storage Temp. i.e., up to 40oC
for the quoted item
Valid upto 10/07/2015
YES (The required Turn Over is
more than Rs. 5 Crores for each year during the last 3 financial
year)
Furnished Not Qualified
after sample verification.
3
Technical Evaluation for the Tenderof Diffrent Anti Malaria Drugs 2015 - 16
Bid Reference No. OSMCL/2014-15/DRUGS-DHS-Mal./01 Annexure : II
GMP / WHO GMP
Manufacturing/Import
License Specification Name of the Item Sl No. Remarks Reason of Rejection
Market Standing
Certificate
Market Experience
Declaration Form
Unit / Pack Size
Annual Turn Over
EMD: Tender Cost (Rs. 2,100/- ): Yes 1 M/s. CIRON DRUGS AND PHARMACUTICALS PVT. LTD. ,Mumbai 2,21,000
60 mg/Vial (with Sodium Bi-carbonate 1 ml+5ml NaCl)
Inj. Artesunate D14018 1 . 7 Vials/Box
Valid upto 31/12/2016
YES WHO GMP valid upto
02/03/2016
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
EMD: Tender Cost (Rs. 2,100/- ): Yes 2 M/s. UNICURE INDIA LTD. ,Noida 2,04,000
100 mg / Tab as per IP 1996 / latest IP.The Shelf life of Tab. DEC should be minimum three years to maximum five years.
Tab. Diethylcarbamazine Citrate (Aluminium Foil / Blister Pack)
D09143 1 30 Tabs/Strip 25 Strips/Box
Valid upto 31/12/2016
YES Valid upto 05/06/2015
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
7.5 mg/Tab,13 mg of primaquin phosphate equivalent to 7.5 mg of primaquin
Tab. Primaquin Phosphate (Coated) (Aluminium foil/Blister pack)
D14006 2 10 Tabs/Strip 10 Strips/Box
Valid upto 31/12/2016
YES Valid upto 05/06/2015
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
2.5mg/Tab. Tab. Primaquin Phosphate (coated) (Aluminium foil/Blister pack)
D14035 3 10 Tabs/Strip 10 Strips/Box
Valid upto 31/12/2016
YES Valid upto 05/06/2015
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
1
GMP / WHO GMP
Manufacturing/Import
License Specification Name of the Item Sl No. Remarks Reason of Rejection
Market Standing
Certificate
Market Experience
Declaration Form
Unit / Pack Size
Annual Turn Over
EMD: Tender Cost (Rs. 2,100/- ): Yes 3 M/s. MINOPHARM LABORATORIES (P) LTD. ,Hyderabad 4,25,000
100 mg / Tab as per IP 1996 / latest IP.The Shelf life of Tab. DEC should be minimum three years to maximum five years.
Tab. Diethylcarbamazine Citrate (Aluminium Foil / Blister Pack)
D09143 1 30 Tabs/Strip 25 Strips/Box
Valid upto 30/09/2016
YES Valid upto 11/01/2016
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
7.5 mg/Tab,13 mg of primaquin phosphate equivalent to 7.5 mg of primaquin
Tab. Primaquin Phosphate (Coated) (Aluminium foil/Blister pack)
D14006 2 10 Tabs/Strip 10 Strips/Box
Valid upto 30/09/2016
YES Valid upto 11/01/2016
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
60 mg/Vial (with Sodium Bi-carbonate 1 ml+5ml NaCl)
Inj. Artesunate D14018 3 . 7 Vials/Box
Valid upto 30/09/2016
YES Valid upto 11/01/2016
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
2.5mg/Tab. Tab. Primaquin Phosphate (coated) (Aluminium foil/Blister pack)
D14035 4 10 Tabs/Strip 10 Strips/Box
Valid upto 30/09/2016
YES Valid upto 11/01/2016
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
2
GMP / WHO GMP
Manufacturing/Import
License Specification Name of the Item Sl No. Remarks Reason of Rejection
Market Standing
Certificate
Market Experience
Declaration Form
Unit / Pack Size
Annual Turn Over
EMD: Tender Cost (Rs. 2,100/- ): Yes 4 M/s. MODERN LABORATORIES ,Indore 3,05,150
300 mg/Tab Tab. Quinine Sulphate (Coated) (Aluminium foil/Blister pack)
D14004 1 10 Tabs/Strip 10 Strips/Box
Valid upto 31/12/2016
YES Valid upto 17/05/2015
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
300 mg/ml Inj. Quinine Di-Hydrochloride D14005 2 2 ml/Amp 20 Amps/Box
Valid upto 31/12/2016
YES Valid upto 17/05/2015
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
7.5 mg/Tab,13 mg of primaquin phosphate equivalent to 7.5 mg of primaquin
Tab. Primaquin Phosphate (Coated) (Aluminium foil/Blister pack)
D14006 3 10 Tabs/Strip 10 Strips/Box
Valid upto 31/12/2016
YES Valid upto 17/05/2015
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
60 mg/Vial (with Sodium Bi-carbonate 1 ml+5ml NaCl)
Inj. Artesunate D14018 4 . 7 Vials/Box
Valid upto 31/12/2016
YES Valid upto 17/05/2015
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
2.5mg/Tab. Tab. Primaquin Phosphate (coated) (Aluminium foil/Blister pack)
D14035 5 10 Tabs/Strip 10 Strips/Box
Valid upto 31/12/2016
YES Valid upto 17/05/2015
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
3
GMP / WHO GMP
Manufacturing/Import
License Specification Name of the Item Sl No. Remarks Reason of Rejection
Market Standing
Certificate
Market Experience
Declaration Form
Unit / Pack Size
Annual Turn Over
EMD: Tender Cost (Rs. 2,100/- ): Yes 5 M/s. HINDUSTAN LABORATORIES ,Mumbai 1,30,000
100 mg / Tab as per IP 1996 / latest IP.The Shelf life of Tab. DEC should be minimum three years to maximum five years.
Tab. Diethylcarbamazine Citrate (Aluminium Foil / Blister Pack)
D09143 1 30 Tabs/Strip 25 Strips/Box
Valid upto 03/05/2016
YES Valid upto 22/01/2017
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
EMD: Tender Cost (Rs. 2,100/- ): Yes 6 M/s. PURE PHARMA LIMITED ,Indore 1,30,000
100 mg / Tab as per IP 1996 / latest IP.The Shelf life of Tab. DEC should be minimum three years to maximum five years.
Tab. Diethylcarbamazine Citrate (Aluminium Foil / Blister Pack)
D09143 1 30 Tabs/Strip 25 Strips/Box
Valid upto 31/12/2017
YES Valid upto 03/08/2015
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
EMD: Tender Cost (Rs. 2,100/- ): Yes 7 M/s. VIVEK PHARMACHEM INDIA LIMITED ,Jaypur 1,30,000
100 mg / Tab as per IP 1996 / latest IP.The Shelf life of Tab. DEC should be minimum three years to maximum five years.
Tab. Diethylcarbamazine Citrate (Aluminium Foil / Blister Pack)
D09143 1 30 Tabs/Strip 25 Strips/Box
Valid upto 24/10/2016
YES Valid upto 22/12/2015
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
4
GMP / WHO GMP
Manufacturing/Import
License Specification Name of the Item Sl No. Remarks Reason of Rejection
Market Standing
Certificate
Market Experience
Declaration Form
Unit / Pack Size
Annual Turn Over
EMD: Tender Cost (Rs. 2,100/- ): Yes 8 M/s. ZEE LABORATORIES ,Paonta Sahib (HP) 2,23,500
300 mg/Tab Tab. Quinine Sulphate (Coated) (Aluminium foil/Blister pack)
D14004 1 10 Tabs/Strip 10 Strips/Box
Valid upto 03/04/2015
YES Valid upto 27/06/2015
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
60 mg/Vial (with Sodium Bi-carbonate 1 ml+5ml NaCl)
Inj. Artesunate D14018 2 . 7 Vials/Box
Valid upto 03/04/2015
YES Valid upto 27/06/2015
YES (The required Turn Over is more than Rs. 15 Crores for
each year during the last
3 financial year)
Furnished Qualified YES
5
Technical Evaluation for the Tender of Anti Malaria Combipacks 2015 - 16
Bid Reference No. OSMCL/2014-15/DRUGS-DHS-CP/02 Annexure : III
GMP / WHO GMP/COPP
Manufacturing/Import License Specification Name of the Item
Sl No. Remarks Reason of Rejection
Market Standing
Certificate
Market Experience
Declaration Form
Unit / Pack Size
Annual Turn Over
EMD: Tender Cost (Rs. 5,250/- ): Yes 1 M/s. ZEST PHARMA ,Indore 5,94,000
Tab. Anti-Malarial Combipack (Blister Pack) Children 1 - 4 years
D14024 1 . 25 FDCs / Box
Valid upto 29/11/2016
Valid upto 29/11/2016
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 50mg) and one tablet of Sulphadoxine and Pyrimethamine (500mg + 25mg) Second Row (Day 2): one tablet of Artesunate 50mg Third Row (Day 3): one tablet of Artesunate 50mg.
Tab. Anti-Malarial Combipack (Blister Pack) Children 5 - 8 years
D14025 2 . 25 FDCs / Box
Valid upto 29/11/2016
Valid upto 29/11/2016
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 100mg) and one tablet of Sulphadoxine and Pyrimethamine (750mg + 37.5mg) Second Row (Day 2): one tablet of Artesunate 100mg Third Row (Day 3): one tablet of Artesunate 100mg.
Tab. Anti-Malarial Combipack (Blister Pack) Children 9 - 14 years
D14026 3 . 25 FDCs / Box
Valid upto 29/11/2016
Valid upto 29/11/2016
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 150mg) and two tablets of Sulphadoxine and Pyrimethamine (500mg + 25mg) each Second Row (Day 2): one tablet of Artesunate 150mg Third Row (Day 3): one tablet of Artesunate 150mg.
1
GMP / WHO GMP/COPP
Manufacturing/Import License Specification Name of the Item
Sl No. Remarks Reason of Rejection
Market Standing
Certificate
Market Experience
Declaration Form
Unit / Pack Size
Annual Turn Over
Tab. Anti-Malarial Combipack (Blister Pack) (Adults 15 year and above)
D38013 4 Each 1 Kit / Box
Valid upto 29/11/2016
Valid upto 29/11/2016
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
Each Row - No. of tablets First Row (Day 1): One tablet of Artesunate (i.e. 1 tablet of 200mg) and two tablets of Sulphadoxine and Pyrimethamine (750mg + 37.5mg) each Second Row (Day 2): one tablet of Artesunate 200mg Third Row (Day 3): one tablet of Artesunate 200mg or 3 tablets of Sulphadoxine Pyremethamine (500+25) mg each 2nd Row (Day 2) : One tablet of Aresunate (200 mg) 3rd Row (Day 3) : One tablet of Artesunate (200 mg).
2
GMP / WHO GMP/COPP
Manufacturing/Import License Specification Name of the Item
Sl No. Remarks Reason of Rejection
Market Standing
Certificate
Market Experience
Declaration Form
Unit / Pack Size
Annual Turn Over
EMD: Tender Cost (Rs. 5,250/- ): Yes 2 M/s. HEALTHY LIFE PHARMA PVT. LTD. ,Mumbai 6,18,500
Tab. Anti-Malarial Combipack (Blister Pack) Infant less than 1 year
D14023 1 . 25 FDCs / Box
NO (Combination of composition
furnished by the bidder in its
Drug Endorsement is not matching )
Valid upto 09/04/2016
NO Furnished NO (As per
performance statement
furnished by the Bidder in support
of market experience for
coated item for last 3 years is not as per tender clause
No. 5.2.8 .)
YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Not Qualified
The quoted item specification(composition)
is not matching with the composition of the tender
item ,No market experience & No market standing as per
tender clause no 5.2.8 & 5.2.9 respectively.
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 25mg) and one tablet of Sulphadoxine and Pyrimethamine (250mg + 12.5mg) Second Row (Day 2): one tablet of Artesunate 25mg Third Row (Day 3): one tablet of Artesunate 25mg.
Tab. Anti-Malarial Combipack (Blister Pack) Children 1 - 4 years
D14024 2 . 25 FDCs / Box
Valid upto 31/12/2017
Valid upto 09/04/2016
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 50mg) and one tablet of Sulphadoxine and Pyrimethamine (500mg + 25mg) Second Row (Day 2): one tablet of Artesunate 50mg Third Row (Day 3): one tablet of Artesunate 50mg.
Tab. Anti-Malarial Combipack (Blister Pack) Children 5 - 8 years
D14025 3 . 25 FDCs / Box
Valid upto 31/12/2017
Valid upto 09/04/2016
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 100mg) and one tablet of Sulphadoxine and Pyrimethamine (750mg + 37.5mg) Second Row (Day 2): one tablet of Artesunate 100mg Third Row (Day 3): one tablet of Artesunate 100mg.
Tab. Anti-Malarial Combipack (Blister Pack) Children 9 - 14 years
D14026 4 . 25 FDCs / Box
Valid upto 31/12/2017
Valid upto 09/04/2016
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 150mg) and two tablets of Sulphadoxine and Pyrimethamine (500mg + 25mg) each Second Row (Day 2): one tablet of Artesunate 150mg Third Row (Day 3): one tablet of Artesunate 150mg.
3
GMP / WHO GMP/COPP
Manufacturing/Import License Specification Name of the Item
Sl No. Remarks Reason of Rejection
Market Standing
Certificate
Market Experience
Declaration Form
Unit / Pack Size
Annual Turn Over
Tab. Anti-Malarial Combipack (Blister Pack) (Adults 15 year and above)
D38013 5 Each 1 Kit / Box
Valid upto 31/12/2017
Valid upto 09/04/2016
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
Each Row - No. of tablets First Row (Day 1): One tablet of Artesunate (i.e. 1 tablet of 200mg) and two tablets of Sulphadoxine and Pyrimethamine (750mg + 37.5mg) each Second Row (Day 2): one tablet of Artesunate 200mg Third Row (Day 3): one tablet of Artesunate 200mg or 3 tablets of Sulphadoxine Pyremethamine (500+25) mg each 2nd Row (Day 2) : One tablet of Aresunate (200 mg) 3rd Row (Day 3) : One tablet of Artesunate (200 mg).
4
GMP / WHO GMP/COPP
Manufacturing/Import License Specification Name of the Item
Sl No. Remarks Reason of Rejection
Market Standing
Certificate
Market Experience
Declaration Form
Unit / Pack Size
Annual Turn Over
EMD: Tender Cost (Rs. 5,250/- ): Yes 3 M/s. UNICURE INDIA LTD. ,Noida 6,18,500
Tab. Anti-Malarial Combipack (Blister Pack) Infant less than 1 year
D14023 1 . 25 FDCs / Box
Valid upto 31/12/2016
Valid upto 05/06/2015
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 25mg) and one tablet of Sulphadoxine and Pyrimethamine (250mg + 12.5mg) Second Row (Day 2): one tablet of Artesunate 25mg Third Row (Day 3): one tablet of Artesunate 25mg.
Tab. Anti-Malarial Combipack (Blister Pack) Children 1 - 4 years
D14024 2 . 25 FDCs / Box
Valid upto 31/12/2016
Valid upto 05/06/2015
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 50mg) and one tablet of Sulphadoxine and Pyrimethamine (500mg + 25mg) Second Row (Day 2): one tablet of Artesunate 50mg Third Row (Day 3): one tablet of Artesunate 50mg.
Tab. Anti-Malarial Combipack (Blister Pack) Children 5 - 8 years
D14025 3 . 25 FDCs / Box
Valid upto 31/12/2016
Valid upto 05/06/2015
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 100mg) and one tablet of Sulphadoxine and Pyrimethamine (750mg + 37.5mg) Second Row (Day 2): one tablet of Artesunate 100mg Third Row (Day 3): one tablet of Artesunate 100mg.
Tab. Anti-Malarial Combipack (Blister Pack) Children 9 - 14 years
D14026 4 . 25 FDCs / Box
Valid upto 31/12/2016
Valid upto 05/06/2015
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 150mg) and two tablets of Sulphadoxine and Pyrimethamine (500mg + 25mg) each Second Row (Day 2): one tablet of Artesunate 150mg Third Row (Day 3): one tablet of Artesunate 150mg.
5
GMP / WHO GMP/COPP
Manufacturing/Import License Specification Name of the Item
Sl No. Remarks Reason of Rejection
Market Standing
Certificate
Market Experience
Declaration Form
Unit / Pack Size
Annual Turn Over
Tab. Anti-Malarial Combipack (Blister Pack) (Adults 15 year and above)
D38013 5 Each 1 Kit / Box
Valid upto 31/12/2016
Valid upto 05/06/2015
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
Each Row - No. of tablets First Row (Day 1): One tablet of Artesunate (i.e. 1 tablet of 200mg) and two tablets of Sulphadoxine and Pyrimethamine (750mg + 37.5mg) each Second Row (Day 2): one tablet of Artesunate 200mg Third Row (Day 3): one tablet of Artesunate 200mg or 3 tablets of Sulphadoxine Pyremethamine (500+25) mg each 2nd Row (Day 2) : One tablet of Aresunate (200 mg) 3rd Row (Day 3) : One tablet of Artesunate (200 mg).
6
GMP / WHO GMP/COPP
Manufacturing/Import License Specification Name of the Item
Sl No. Remarks Reason of Rejection
Market Standing
Certificate
Market Experience
Declaration Form
Unit / Pack Size
Annual Turn Over
EMD: Tender Cost (Rs. 5,250/- ): Yes 4 M/s. SALUD CARE (INDIA) PVT. LTD. ,Ahmedabad 6,18,500
Tab. Anti-Malarial Combipack (Blister Pack) Infant less than 1 year
D14023 1 . 25 FDCs / Box
Valid upto 01/12/2016
Valid upto 16/05/2015
YES Furnished NO (As per
performance statement
furnished by the Bidder in support
of market experience for
coated item for last 3 years is not as per tender clause
No. 5.2.8 .)
YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Not Qualified
No market experience for quoted item for last 3 years as per tender clause No. 5.2.8 .
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 25mg) and one tablet of Sulphadoxine and Pyrimethamine (250mg + 12.5mg) Second Row (Day 2): one tablet of Artesunate 25mg Third Row (Day 3): one tablet of Artesunate 25mg.
Tab. Anti-Malarial Combipack (Blister Pack) Children 1 - 4 years
D14024 2 . 25 FDCs / Box
Valid upto 01/12/2016
Valid upto 16/05/2015
YES Furnished NO (As per
performance statement
furnished by the Bidder in support
of market experience for
coated item for last 3 years is not as per tender clause
No. 5.2.8 .)
YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Not Qualified
No market experience for quoted item for last 3 years as per tender clause No. 5.2.8 .
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 50mg) and one tablet of Sulphadoxine and Pyrimethamine (500mg + 25mg) Second Row (Day 2): one tablet of Artesunate 50mg Third Row (Day 3): one tablet of Artesunate 50mg.
Tab. Anti-Malarial Combipack (Blister Pack) Children 5 - 8 years
D14025 3 . 25 FDCs / Box
Valid upto 01/12/2016
Valid upto 16/05/2015
YES Furnished NO (As per
performance statement
furnished by the Bidder in support
of market experience for
coated item for last 3 years is not as per tender clause
No. 5.2.8 .)
YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Not Qualified
No market experience for quoted item for last 3 years as per tender clause No. 5.2.8 .
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 100mg) and one tablet of Sulphadoxine and Pyrimethamine (750mg + 37.5mg) Second Row (Day 2): one tablet of Artesunate 100mg Third Row (Day 3): one tablet of Artesunate 100mg.
7
Sd/
Managing Director, OSMC
GMP / WHO GMP/COPP
Manufacturing/Import License Specification Name of the Item
Sl No. Remarks Reason of Rejection
Market Standing
Certificate
Market Experience
Declaration Form
Unit / Pack Size
Annual Turn Over
Tab. Anti-Malarial Combipack (Blister Pack) Children 9 - 14 years
D14026 4 . 25 FDCs / Box
Valid upto 01/12/2016
Valid upto 16/05/2015
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
(Day 1): One tablet of Artesunate (i.e. 1 tablet of 150mg) and two tablets of Sulphadoxine and Pyrimethamine (500mg + 25mg) each Second Row (Day 2): one tablet of Artesunate 150mg Third Row (Day 3): one tablet of Artesunate 150mg.
Tab. Anti-Malarial Combipack (Blister Pack) (Adults 15 year and above)
D38013 5 Each 1 Kit / Box
Valid upto 01/12/2016
Valid upto 16/05/2015
YES Furnished YES YES (The required Turn
Over is more than Rs. 10 Crores for each year
during the last 3 financial year)
Qualified
Each Row - No. of tablets First Row (Day 1): One tablet of Artesunate (i.e. 1 tablet of 200mg) and two tablets of Sulphadoxine and Pyrimethamine (750mg + 37.5mg) each Second Row (Day 2): one tablet of Artesunate 200mg Third Row (Day 3): one tablet of Artesunate 200mg or 3 tablets of Sulphadoxine Pyremethamine (500+25) mg each 2nd Row (Day 2) : One tablet of Aresunate (200 mg) 3rd Row (Day 3) : One tablet of Artesunate (200 mg).
8